These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 23026200
21. FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex. Xia W, Ostaszewski BL, Kimberly WT, Rahmati T, Moore CL, Wolfe MS, Selkoe DJ. Neurobiol Dis; 2000 Dec; 7(6 Pt B):673-81. PubMed ID: 11114265 [Abstract] [Full Text] [Related]
22. [Generation of Tau/App/PS1 triple-transgenic mouse model and the study of its biological characteristics]. Wang LL, Na X, Zhu XN, Chen RZ, Wang H, Wang XL. Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Jul; 28(4):294-7. PubMed ID: 23156717 [Abstract] [Full Text] [Related]
23. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease. Guo C, Wang T, Zheng W, Shan ZY, Teng WP, Wang ZY. Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236 [Abstract] [Full Text] [Related]
24. Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels. Deng QS, Dong XY, Wu H, Wang W, Wang ZT, Zhu JW, Liu CF, Jia WQ, Zhang Y, Schachner M, Ma QH, Xu RX. Neuropsychopharmacology; 2016 Jan; 41(2):440-53. PubMed ID: 26062786 [Abstract] [Full Text] [Related]
25. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing. Kumar VB, Franko M, Banks WA, Kasinadhuni P, Farr SA, Vyas K, Choudhuri V, Morley JE. J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896 [Abstract] [Full Text] [Related]
32. Hydrogen sulfide improves spatial memory impairment and decreases production of Aβ in APP/PS1 transgenic mice. He XL, Yan N, Zhang H, Qi YW, Zhu LJ, Liu MJ, Yan Y. Neurochem Int; 2014 Feb; 67():1-8. PubMed ID: 24412510 [Abstract] [Full Text] [Related]
33. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease. Jackson RJ, Rudinskiy N, Herrmann AG, Croft S, Kim JM, Petrova V, Ramos-Rodriguez JJ, Pitstick R, Wegmann S, Garcia-Alloza M, Carlson GA, Hyman BT, Spires-Jones TL. Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574 [Abstract] [Full Text] [Related]
37. Analysis of Non-Amyloidogenic Mutations in APP Supports Loss of Function Hypothesis of Alzheimer's Disease. Kim M, Bezprozvanny I. Int J Mol Sci; 2023 Jan 20; 24(3):. PubMed ID: 36768421 [Abstract] [Full Text] [Related]